University of Hertfordshire

New Psychoactive Substances and suicidality: a systematic review of the current literature.

Research output: Contribution to journalReview articlepeer-review

Documents

  • Stefania Chiappini
  • Alessio Mosca
  • A. Miuli
  • Monica Chiara Santovito
  • Laura Orsolini
  • John Martin Corkery
  • Amira Guirguis
  • Mauro Pettorruso
  • Giovanni Martinotti
  • Massimo di Giannantonio
  • Fabrizio Schifano
View graph of relations
Original languageEnglish
Article number1214747
Number of pages23
JournalMedicina
Volume57
Issue6
Early online date6 Jun 2021
DOIs
Publication statusE-pub ahead of print - 6 Jun 2021

Abstract

Background and Objectives: Over the past twenty years a large number of New Psychoactive Substances (NPS) has entered and modified the recreational drug scene. Their intake has been associated with health-related risks, and especially so for vulnerable populations such as people with severe mental illness, who might be at higher risk of suicidality or self- injurious behaviour.
This paper aims at providing an overview of NPS abuse and effects on mental health and suicidality issues, performing a literature review of the current related knowledge, thereby identifying substances that more than others are linked to suicidal behaviours.
Materials and Methods: A comprehensive and updated overview of the literature regarding suicidality and NPS categories has been provided. An electronic search was performed, including all papers published up to March 2021, using the following keywords "NPS" OR "new psychoactive substances" OR "novel psychoactive substances" OR "synthetic cannabinoids" OR "phenethylamines" OR "synthetic cathinones" OR “tryptamines” OR “piperazines” OR “new synthetic opioids” OR “designer benzodiazepines”) AND ("suicide" OR "suicidality") NOT review NOT animal on the PubMed, Cochrane Library, and Web of Science online databases.
Results: Suicidality and self-injurious behaviour appear to be frequently associated with some NPS such as cathinones, synthetic cannabinoids, and new synthetic opioids. Results are organised according to substances recorded.
Conclusion: The growing use of NPS has become a significant clinical issue, posing increasing concern and challenges for clinicians working in both mental health and emergency departments. Thus, considering the associations between NPS and suicidality or self-injurious behaviours, areas where suicide-prevention efforts and strategies might be focused are the early detection, monitoring and restriction of NPS.

Notes

Submitted 23 April 2021. Minor revisions requested 31 May 2021. Revisions submitted 3 June 2021. Accepted 3 June 2021. Epub 6 June 2021.

ID: 25367286